C3aR antagonist SB290157 reduced the inhibitory Ser9 phosphorylation of glycogen synthase 3β (GSK3β) in the SH-SY5Y neuroblastoma cells [51], pointing to the role of C3aR signaling in the regulation of GSK3β activity, Fig. 2. This evidence concerns the gene GSK3B and neuroblastoma.